) The goal of this proposal, titled """"""""Integrating Cancer and Aging at Pitt"""""""", is to establish a standing Cancer and Aging Program within the University of Pittsburgh Cancer Institute. The core mission of the Cancer and Aging Program will be to develop and test interventions to improve health outcomes in older persons with cancer. In order to develop the Cancer and Aging Program, over the next five years, we will 1) implement a series of activities designed to reduce barriers and promote collaboration, 2) perform pilot translational research studies to better understand the immunobiology of cancer in elderly patients and apply insights to develop more effective treatment, 3) collect, develop, evaluate and disseminate aging-relevant measures of co-morbidity, functioning and cancer outcomes, and 4) develop and test promising medical, behavioral and social interventions for older people with cancer. We will build on institutional strengths to expand collaborative research in three main areas identified in the Aging and Cancer Workshop Report; 1) translational research on immunobiology of cancer and aging, 2) clinical trials of treatment efficacy and tolerance in the context of age related co-morbidity and 3) behavioral and social issues in older cancer patients. Since cancer care planning should depend not on chronological age, but on life expectancy, ability to tolerate treatment, and patient goals, we envision developing a spectrum of care strategies tailored to the individual health and functional status of the cancer patient aged 65 and over. In order to further identify barriers to collaborative research on aging and cancer, and to design strategies to overcome them, we plan a first year series of interactions with critical constituencies from academics and clinical practice at Pitt, with clinicians from the region, and with older cancer survivors and caregivers in the community. We see successful collaboration as dependent on our ability to accommodate and incorporate each potential contributor's perspective, experience and priorities. In order to sustain a feedback loop between our constituencies and our Program, we propose standing academic, clinical and community advisory groups. This proposal includes plans for: 1) a series of workshops and retreats designed to engage representatives from all of the relevant disciplines and constituencies, identify possible barriers to the success of the Program and implement strategies to overcome them, 2) seminars and conferences designed to promote innovative and collaborative research in cancer and aging, 3) a pilot research program to support initial projects considered to be of high scientific quality and of central relevance to the goals of the Program, 4) development of a new Measurement in Aging and Cancer Resource Core, 5) the inclusion of aging issues into relevant existing programs and shared resource facilities of the UPCI and 6) inclusion of cancer issues into major programs of the University of Pittsburgh Institute on Aging (UPIA).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory Grants (P20)
Project #
5P20CA103730-05
Application #
7284241
Study Section
Special Emphasis Panel (ZCA1-GRB-H (O1))
Program Officer
Vembu, Devi
Project Start
2003-09-30
Project End
2010-08-31
Budget Start
2007-09-01
Budget End
2010-08-31
Support Year
5
Fiscal Year
2007
Total Cost
$618,580
Indirect Cost
Name
University of Pittsburgh
Department
Pathology
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Zhao, Jing; Li, Xuesen; McGowan, Sara et al. (2015) NF-?B activation with aging: characterization and therapeutic inhibition. Methods Mol Biol 1280:543-57
Tilstra, Jeremy S; Gaddy, Daniel F; Zhao, Jing et al. (2014) Pharmacologic IKK/NF-?B inhibition causes antigen presenting cells to undergo TNF? dependent ROS-mediated programmed cell death. Sci Rep 4:3631
Hudson, Alana G; Reeves, Katherine W; Modugno, Francesmary et al. (2013) Erythrocyte omega-6 and omega-3 fatty acids and mammographic breast density. Nutr Cancer 65:410-6
Xun, Zhiyin; Rivera-Sánchez, Sulay; Ayala-Peña, Sylvette et al. (2012) Targeting of XJB-5-131 to mitochondria suppresses oxidative DNA damage and motor decline in a mouse model of Huntington's disease. Cell Rep 2:1137-42
Tilstra, Jeremy S; Robinson, Andria R; Wang, Jin et al. (2012) NF-?B inhibition delays DNA damage-induced senescence and aging in mice. J Clin Invest 122:2601-12
Kovacs, J R; Li, C; Yang, Q et al. (2012) Autophagy promotes T-cell survival through degradation of proteins of the cell death machinery. Cell Death Differ 19:144-52
Ghosh, Hiyaa Singhee; Reizis, Boris; Robbins, Paul D (2011) SIRT1 associates with eIF2-alpha and regulates the cellular stress response. Sci Rep 1:150
Tomaszewski, Jeffrey J; Cummings, Jessica L; Parwani, Anil V et al. (2011) Increased cancer cell proliferation in prostate cancer patients with high levels of serum folate. Prostate 71:1287-93
Powolny, Anna A; Singh, Shivendra V; Melov, Simon et al. (2011) The garlic constituent diallyl trisulfide increases the lifespan of C. elegans via skn-1 activation. Exp Gerontol 46:441-52
Wieckowski, Eva; Chatta, Gurkamal S; Mailliard, Robbie M et al. (2011) Type-1 polarized dendritic cells loaded with apoptotic prostate cancer cells are potent inducers of CD8(+) T cells against prostate cancer cells and defined prostate cancer-specific epitopes. Prostate 71:125-33

Showing the most recent 10 out of 47 publications